Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PRKDC | P78527 | 5/20 | 0.34 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.32 |
| ▸ | G6PD | P11413 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22107324 | 0.94 | ALOX5 (0.38) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL22107269 | 0.94 | BRDT (0.33) | ALOX5BRDTG6PD | |
| SCHEMBL22107180 | 0.91 | ALOX5 (0.35) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL22107428 | 0.91 | ALOX5 (0.37) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL22107272 | 0.89 | ALOX5 (0.38) | ALOX5PRKDC | |
| SCHEMBL22107219 | 0.89 | ALOX5 (0.45) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL22107271 | 0.88 | ALOX5 (0.38) | ALOX5PRKDC | |
| SCHEMBL17115297 | 0.88 | G6PD (0.34) | G6PD | |
| SCHEMBL17115296 | 0.88 | G6PD (0.34) | G6PD | |
| SCHEMBL18713343 | 0.88 | G6PD (0.34) | G6PD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11683982-B2 | Organic compound having excellent thermal resistance property and luminescent property, organic light emitting diode and organic light emitting device having the compound | LG DISPLAY CO., LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| US-11683982-B2 | Organic compound having excellent thermal resistance property and luminescent property, organic light emitting diode and organic light emitting device having the compound | LG DISPLAY CO., LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| WO-2020122451-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2020-06-18 | — | — | WO | disclosed |
| US-20200194685-A1 | ORGANIC COMPOUND HAVING EXCELLENT THERMAL RESISTANCE PROPERTY AND LUMINESCENT PROPERTY, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | LG DISPLAY CO., LTD. (KR) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11683982-B2 | Organic compound having excellent thermal resistance property and luminescent property, organic light emitting diode and organic light emitting device having the compound | DDT, DBF4, L3MBTL4 | ALOX5 2142/4885PRKDC 979/4885PARP14 1556/4885 |
| US-20200194685-A1 | ORGANIC COMPOUND HAVING EXCELLENT THERMAL RESISTANCE PROPERTY AND LUMINESCENT PROPERTY, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | DDT, DBF4, L3MBTL4 | ALOX5 2142/4885PRKDC 979/4885PARP14 1556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.